Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 3, 2005, Pages 1181-1183

  Bourne, Nigel ^a   Stegall, Rachael ^a   Montano, Raquel ^a   Meador, Michael ^a   Stanberry, Lawrence R ^a   Milligan, Gregg N ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCONATE ZINC; ZINC ACETATE; ZINC DERIVATIVE; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAGINA EPITHELIUM; VAGINITIS;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; FEMALE; HERPES GENITALIS; MICE; ZINC ACETATE; ZINC COMPOUNDS; ZINC SULFATE;

EID: 14744273552     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.3.1181-1183.2005     Document Type: Article

References (22)

1. Arens, M., and S. Travis. 2000. Zinc salts inactivate clinical isolates of herpes simplex virus in vitro. J. Clin. Microbiol. 38:1758-1762.
2. Bourne, N., D. I. Bernstein, J. Ireland, A. J. Sonderfan, A. T. Profy, and L. R. Stanberry. 1999. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. J. Infect. Dis. 180:203-205.
3. Bourne, N., L. R. Stanberry, E. R. Kern, G. Holan, B. Matthews, and D. I. Bernstein. 2000. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob. Agents Chemother. 44:2471-2474.
4. Bourne, N., L. J. D. Zaneveld, J. A. Ward, J. P. Ireland, and L. R. Stanberry. 2003. Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex type 2 and Chlamydia trachomatis infection in mice. Clin. Microbiol. Infect. 9:816-822.
5. Catalone, B. J., T. M. Kish-Catalone, L. R. Bubgeon, E. B. Neely, M. Ferguson, F. C. Krebs, M. K. Howett, M. Labib, R. Rando, and B. Wigdahl. 2004. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob. Agents Chemother. 48:1837-1847.
6. D'Cruz, O. J., and F. M. Uckun. 2004. Clinical development of microbicides for the prevention of HIV infection. Curr. Pharm. Des. 10:315-336.
7. Eby, G. A., and W. W. Halcomb. 1985. Use of topical zinc to prevent recurrent herpes simplex infections: review of the literature and suggested protocols. Med. Hypotheses 17:157-165.
8. Fichorova, R. N., L. D. Tucker, and D. J. Anderson. 2001. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1. J. Infect. Dis. 184:418-428.
9. Geist, F. C., J. A. Bateman, and F. G. Hayden. 1987. In vitro activity of zinc salts against human rhinoviruses. Antimicrob. Agents Chemother. 31:622-624.
10. Godfrey, H. R., N. J. Godfrey, J. C. Godfrey, and D. Riley. 2001. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern. Ther. Health Med. 7:49-56.
11. Greenberg, S. B., D. Harris, P. Giles, R. R. Martin, and R. J. Wallace, Jr. 1985. Inhibition of Chlamydia trachomatis growth in McCoy, HeLa, and human prostate cells by zinc. Antimicrob. Agents Chemother. 27:953-957.
12. Haraguchi, Y., H. Sakurai, S. Hussain, B. M. Anner, and H. Hoshino. 1999. Inhibition of HIV-1 infection by zinc group metal compounds. Antiviral Res. 43:123-133.
13. Keller, M. J., M. E. Klotman, and B. C. Herold. 2003. Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus. J. Antimicrob. Chemother. 51:1099-1102.
14. Merluzzi, V. J., D. Cipriano, D. McNeil, V. Fuchs, C. Supeau, A. S. Rosenthal, and J. W. Skiles. 1989. Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro. Res. Commun. Chem. Pathol. Pharmacol. 66:425-440.
15. Milligan, G. N., K. L. Dudley, N. Bourne, A. L. Reece, and L. R. Stanberry. 2002. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents. Sex. Transm. Dis. 29:597-605.
16. Stafford, M. K., H. Ward, A. Flanagan, I. J. Rosenstein, D. Taylor-Robinson, J. R. Smith, J. Weber, and V. S. Kitchen. 1998. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17:327-331.
17. Suara, R. O., and J. E. Crowe, Jr. 2004. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob. Agents Chemother. 48:783-790.
18. Sugarman, B., and L. R. Epps. 1985. Zinc and Chlamydia trachomatis. Proc. Soc. Exp. Biol. Med. 179:382-387.
19. Tennican, P., G. Carl., J. Frey, C. Theis, and M. Chvapil. 1980. Topical zinc in the treatment of mice infected intravaginally with herpes genitalis virus. Proc. Soc. Exp. Biol. Med. 164:593-597.
20. Tennican, P. O., G. Z. Carl, and M. Chvapil. 1979. The diverse effects of topical and systemic administration of zinc on the virulence of herpes genitalis. Life Sci. 24:1877-1884.
21. World Health Organization. 2002. WHO/CONRAD technical consultation on nonoxynol-9, World Health Organization, Geneva, 9-10 October 2001: summary report. Reprod. Health Matters 10:175-181.
22. Zeitlin, L., K. J. Whaley. 2002. Microbicides for preventing transmission of genital herpes. Herpes 9:4-9.